2a4r: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2a4r.gif|left|200px]] | [[Image:2a4r.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2a4r", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
| | {{STRUCTURE_2a4r| PDB=2a4r | SCENE= }} | ||
| | |||
}} | |||
'''HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.''' | '''HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.''' | ||
Line 35: | Line 32: | ||
[[Category: Prongay, A.]] | [[Category: Prongay, A.]] | ||
[[Category: Saksena, A K.]] | [[Category: Saksena, A K.]] | ||
[[Category: | [[Category: Virus/viral protein]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 18:36:00 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 18:36, 3 May 2008
HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.
OverviewOverview
Modification of the P(2) and P(1) side chains of earlier P(3)-capped alpha-ketoamide inhibitor of HCV NS3 serine protease 1 resulted in the discovery of compound 24 with about 10-fold improvement in potency.
About this StructureAbout this Structure
2A4R is a Protein complex structure of sequences from Hepatitis c virus. Full crystallographic information is available from OCA.
ReferenceReference
Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency., Bogen S, Saksena AK, Arasappan A, Gu H, Njoroge FG, Girijavallabhan V, Pichardo J, Butkiewicz N, Prongay A, Madison V, Bioorg Med Chem Lett. 2005 Oct 15;15(20):4515-9. PMID:16112862 Page seeded by OCA on Sat May 3 18:36:00 2008